SEC Form 4 · accession 0001144204-15-059057
Xtant Medical Holdings, Inc. · XTNT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Louis Kirschman
Officer — EVP & Chief Scientific Officer · Director · 10% Owner
Period of report
Oct 12, 2015
Accepted (ET)
Oct 13, 2015 · 8:36 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001453593
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF1,F2 | — | Oct 12, 2015 | A | 40,000 | A | — | — | Common Stock | 40,000 | 40,000 | D |
Explanation of responses
- F1Each restricted stock unit represents the contingent right to receive one share of Xtant Medical Holdings, Inc. common stock.
- F2The restricted stock units vest as follows: (i) 20%, or 8,000 underlying shares, will vest on the first anniversary of the date of the grant, and (ii) the remaining 80% will vest in 35 equal monthly installments of 914 underlying shares, beginning one month after the first anniversary of the date of the grant, with the remaining 10 shares vesting on the fourth anniversary of the date of grant. Dr. Kirschman must remain employed by Xtant Medical Holdings, Inc. or its subsidiaries for vesting to occur.